Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-03-25 00:00:00 ET · period of report 2024-03-22 · accession 0001628280-24-012915 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-25 | 2024-03-22+ | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $22.24 | -4,893 | 303.0K | -2% | -$108.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-24 | F | D | 1,584 | $22.24 | 299,791 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-24 | F | D | 1,661 | $22.24 | 301,375 | D | — | — | |
| 3 | Common | Common Stock | 2024-03-22 | F | D | 1,648 | $22.24 | 303,036 | D | — | — |